Contenu disponible en anglais seulement.
Bulletin de la Bourse
iShares Genomics Immunology and Healthcare Index ETF (XDNA) inscrit à la Bourse de Toronto
28 avril 2022
Issuer: iShares Genomics Immunology and Healthcare Index ETF (the "ETF")
| Security | Symbol | Issued and Outstanding Securities | Reserved Securities | Issue Price |
|---|---|---|---|---|
| Canadian dollar denominated units (the "CAD Units") | XDNA | 125,000 | None | $40.00 |
| Listing category: | Non-Corporate |
| Trading currency: | CDN$ |
| Transaction: | Initial public offering of CAD Units (the "Offering") |
| Anticipated closing date: | April 28, 2022 |
| Listing date: | April 29, 2022 (as at 5:01 p.m.) subject to confirmation of closing of the Offering. |
| Posted for trading date: | May 2, 2022 (at the opening) subject to confirmation of closing of the Offering. |
| Other market(s): | None |
| Designated market maker: | National Bank Financial Inc. |
| Security ownership registration: | CDS book-entry system, which will be effected in non-certificated form. |
| Investor relations: | Steven Leong Director, iShares Canada 416-933-6410 Steven.leong@blackrock.com |
| Incorporation: | The ETF is an exchange-traded fund established as a trust under the laws of the Province of Ontario pursuant to the amended and restated Declaration of Trust dated April 13, 2022. |
| Manager and Trustee: | BlackRock Asset Management Canada Limited |
| Fiscal year end: | December 31 |
| Nature of business: | The ETF seeks to provide long-term growth by replicating the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index. |
| Transfer agent and registrar: | State Street Trust Company Canada at its principal office in Toronto. |
| Distributions: | Cash distributions on CAD Units of the ETF are expected to be made on a semi-annual basis. |
| Sponsorship: | Not applicable |
| Offering document: | Prospectus dated April 13, 2022 (the "Prospectus"), which is available at www.SEDAR.com. Capitalized terms not otherwise defined herein are as defined in the Prospectus. |
| Initial public offering: | 125,000 CAD Units at a price of $40.00 per CAD Unit. CAD Units are being issued and sold on a continuous basis and there is no maximum number of CAD Units that may be issued. |
| TSX contact: | Selma Thaver, Director, TSX Listings |